Research Article
Optimal Timing of Simethicone Supplement for Bowel Preparation: A Prospective Randomized Controlled Trial
Table 1
Baseline characteristics.
| | | SIM evening group (n = 208) | SIM morning group (n = 211) | value |
| | Gender, n(%) | | Male | 111 (53.4%) | 102 (48.3%) | 0.30a | | Female | 97 (46.6%) | 109 (51.7%) | | | Age (years) | 45.0 (34.3–55.0) | 44.0 (34.0–56.0) | 0.92b | | BMI (kg/m2) | 22.3 ± 2.9 | 22.1 ± 3.7 | 0.52c |
| | Indications for colonoscopy, n (%) | | Constipation | 23 (11.1%) | 24 (11.4%) | 0.99a | | Abdominal pain | 51 (24.5%) | 49 (23.2%) | | | Diarrhea | 35 (16.8%) | 35 (16.6%) | | | Bloating | 5 (2.4%) | 5 (2.4%) | | | Screening CRC | 94 (45.2%) | 98 (46.4%) | |
|
|
Note. BMI, body mass index; CRC, colorectal cancer; a, Pearson’s χ2 test; b, Mann–Whitney test; c, Student’s t-test.
|